Idaho State University: ISU Idaho Accelerator Center announces record production of form of medical isotope copper-67 that will be used in cancer clinical trials
Clarity Pharmaceuticals was featured in Idaho State University News. The Idaho State University Accelerator Center is Clarity’s partner for the production of Copper-67. The article discusses the developments in copper-67 production and the positive effects it has on the expansion of our clinical development program. Read the full article here: https://www.isu.edu/news/2019-spring/isu-idaho-accelerator-center-announces-record-production-of-form-of-medical-isotope-copper-67-that-will-be-used-in-cancer-clinical-trials.html/